RH (NYSE:RH) finished Friday with a subtraction of -$13.53 to close at $371.55, a downside of -3.51 percent. An average of 646,740 shares of common stock have been traded in the last five days. There was a fall of -$21.30 in the past week, and it reached a new high 15 times over the past 12 months. The last 20 days have seen an average of 594,820 shares traded, while the 50-day average volume stands at 769,668.
RH stock has increased by 0.51% in the last month. The company shares reached their 1-month lowest point of $362.51 on 07/17/23. With the stock rallying to its 52-week high on 08/03/23, shares of the company touched a low of $227.00 and a high of $406.38 in 52 weeks. It has reached a new high 21 times so far this year and achieved 39.06% or $104.36 in price. In spite of this, the price is down -8.57% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
RH stock investors should be aware that RH (RH) stock had its last reported insider trading activity 46 days ago on Jun 27. In this transaction, the insider spent $610,473., Lee Edward T, disposed of 1,400 shares at a price of $300.00 on Jun 27. The insider now owns more than $420,000 worth of shares. Prior to that, Director Belling Keith went on to Sale 1,000 shares at $279.99 each on Jun 14. An amount of $279,986 was transacted.
Valuation Metrics
RH (RH) has a trailing price-to-earnings (P/E) ratio of 25.77. The stock’s beta is 2.17. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 2.47, the price-to-book (PB) ratio at 9.76, and the price-to-cash flow ratio at 47.39.
Financial Health
The quick ratio of RH for the three months ended April 29 was 2.00, and the current ratio was 2.90, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 3.70 and a total debt to equity ratio of 3.76 for the quarter ending April 29. RH’s EBITDA margin for the year ending April 29 is 25.90%, while its operating margin for the same period stands at 17.60%. Its gross profit as reported stood at $1.81 billion compared to revenue of $3.59 billion.
Earnings Surprise
For the three-month period that ended April 29, RH had $1.93 billion in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $41.89 million in the quarter, while revenues of $266.8 million were shrunk -379.14%. The analyst consensus anticipated RH’s latest quarter earnings to come in at $2.09 per share, but it turned out to be $2.21, a 5.70% surprise. For the quarter, EBITDA amounted to $146.88 million. Shareholders own equity worth $22.05 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at RH (RH) price momentum. RSI 9-day as of the close on 11 August was 39.98%, suggesting the stock is Neutral, with historical volatility in this time frame at 31.59%.
As of today, RH’s price is $389.72 -5.42% or -$21.30 from its 5-day moving average. RH is currently trading -1.44% lower than its 20-day SMA and +49.44% higher than its 100-day SMA. However, the stock’s current price level is +51.67% above the SMA50 and +58.47% above the SMA200.
The stochastic %K and %D were 29.91% and 51.85%, respectively, and the average true range (ATR) was 11.77. With the 14-day stochastic at 7.44% and the average true range at 11.30, the RSI (14) stands at 50.14%. The stock has reached -8.69 on the 9-day MACD Oscillator while the 14-day reading was at -7.02.
Analyst Ratings
Loop Capital downgraded RH (NYSE: RH) to a a Hold rating in its most recent analyst report. Previously, the stock was rated as a Buy. The consensus rating for RH (RH) among analysts is Hold. According to current brokerage recommendations, 1 brokerage firm advise that investors sell RH, while 12 suggest investors hold. There are 1 analyst who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 6 others rate it as a “buy”.
What is RH’s price target for the next 12 months?
Analysts predict a range of price targets between $176.00 and $460.00, with a median target of $260.00. Taking a look at these predictions, the average price target given by analysts for RH (RH) stock is $305.67.
